Literature DB >> 29256170

Vision-threatening bilateral panuveitis and TRAPS in a child: an uncommon association.

Lidia Cocho1,2, Elena Urbaneja3, José M Herreras4,3.   

Abstract

PURPOSE: To report a childhood case of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) carrying the R92Q variant with a vision-threatening bilateral panuveitis.
METHODS: Case report and review of the literature.
RESULTS: A 7-year-old boy presented with an active bilateral panuveitis and a macular rash associated with fever. Fundus examination showed two choroidal lesions on the posterior pole of the right eye, and fluorescein angiography revealed early hypofluorescence and late hyperfluorescence of the lesions, which were hyper-autofluorescent. Extensive clinical laboratory analyses ruled out autoimmune diseases and systemic infection. The only remarkable finding was a positive IgG for herpes simplex 1. He underwent two successive diagnostic pars plana vitrectomies as well as cataract and glaucoma surgeries. Genetic analysis revealed a mutation in the TNFRSF1A gene, and the patient was diagnosed with TRAPS-associated bilateral panuveitis. He was treated with adalimumab and has been free of active inflammation since then.
CONCLUSIONS: We present here the first case reported of panuveitis in a patient with TRAPS. This finding stresses the increasing importance of genetic analysis in search of autoinflammatory diseases to establish an adequate diagnosis and treatment in cases of uveitis of unknown etiology.

Entities:  

Keywords:  Autoinflammatory diseases; Maculopapular exanthema; Panuveitis; Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

Mesh:

Year:  2017        PMID: 29256170     DOI: 10.1007/s10792-017-0785-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  17 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.

Authors:  K Minden; E Aganna; M F McDermott; A Zink
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 3.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Authors:  N Ravet; S Rouaghe; C Dodé; J Bienvenu; J Stirnemann; P Lévy; M Delpech; G Grateau
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 5.  Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Authors:  Francesco Caso; Luisa Costa; Donato Rigante; Antonio Vitale; Rolando Cimaz; Orso Maria Lucherini; Paolo Sfriso; Elena Verrecchia; Sofia Tognon; Vittoria Bascherini; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Autoimmun Rev       Date:  2014-08-23       Impact factor: 9.754

Review 6.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

7.  Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations.

Authors:  J R Toro; I Aksentijevich; K Hull; J Dean; D L Kastner
Journal:  Arch Dermatol       Date:  2000-12

Review 8.  The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Authors:  Keith M Hull; Elizabeth Drewe; Ivona Aksentijevich; Harjot K Singh; Kondi Wong; Elizabeth M McDermott; Jane Dean; Richard J Powell; Daniel L Kastner
Journal:  Medicine (Baltimore)       Date:  2002-09       Impact factor: 1.889

9.  Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.

Authors:  Ebun Aganna; Linda Hammond; Philip N Hawkins; Anna Aldea; Shane A McKee; Hans Kristian Ploos van Amstel; Claudia Mischung; Koichi Kusuhara; Frank T Saulsbury; Helen J Lachmann; Alison Bybee; Elizabeth M McDermott; Micaela La Regina; Juan I Arostegui; Josep M Campistol; Sharron Worthington; Kevin P High; Michael G Molloy; Nicholas Baker; Jeff L Bidwell; José L Castañer; Margo L Whiteford; P L Janssens-Korpola; Raffaele Manna; Richard J Powell; Patricia Woo; Pilar Solis; Kirsten Minden; Joost Frenkel; Jordi Yagüe; Rita M Mirakian; Graham A Hitman; Michael F McDermott
Journal:  Arthritis Rheum       Date:  2003-09

10.  The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.

Authors:  H J Lachmann; R Papa; K Gerhold; L Obici; I Touitou; L Cantarini; J Frenkel; J Anton; I Kone-Paut; M Cattalini; B Bader-Meunier; A Insalaco; V Hentgen; R Merino; C Modesto; N Toplak; R Berendes; S Ozen; R Cimaz; A Jansson; P A Brogan; P N Hawkins; N Ruperto; A Martini; P Woo; M Gattorno
Journal:  Ann Rheum Dis       Date:  2013-08-21       Impact factor: 19.103

View more
  2 in total

Review 1.  Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors:  Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

2.  Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

Authors:  Wen-Wei Lin; Yun-Chi Lu; Bo-Cheng Huang; Chih-Hung Chuang; Yi-An Cheng; I-Ju Chen; Hui-Ju Liu; Kai-Wen Ho; Tzu-Yi Liao; En-Shuo Liu; Ting-Yi Wu; Long-Sen Chang; Shih-Ting Hong; Tian-Lu Cheng
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.